Immunotoxicology: Opportunities for non-animal test development

Alternatives to Laboratory Animals

Volumn 37, Issue 4, 2009, Pages 387-397

  Corsini, Emanuela ^a   Roggen, Erwin L ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b NOVOZYMES A S   (Denmark)

Author keywords

Allergy; Autoimmunity; Cell lines; Human; Immunosuppression; In vitro immunotoxicology

Indexed keywords

ALLERGEN; B7 ANTIGEN; BIOLOGICAL MARKER; CD40 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 2; INTERLEUKIN 5; XENOBIOTIC AGENT;

ADVERSE OUTCOME; ANIMAL WELFARE; AUTOIMMUNITY; BIOASSAY; CANCER CELL CULTURE; COMPUTER MODEL; CONFERENCE PAPER; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; HYPERSENSITIVITY; IMMUNE SYSTEM; IMMUNOMODULATION; IMMUNOSTIMULATION; IMMUNOTOXICITY; IN VITRO STUDY; IN VIVO STUDY; KERATINOCYTE; MONOCYTIC LEUKEMIA; POLICY; PREDICTION; PRIORITY JOURNAL; RESEARCH ETHICS; RISK ASSESSMENT; SAFETY; SKIN SENSITIZATION; TOXICITY TESTING;

ANIMALIA;

EID: 70449579357     PISSN: 02611929     EISSN: None     Source Type: Journal    
DOI: 10.1177/026119290903700409     Document Type: Conference Paper

References (71)

1. Klein, N.C., Go, C.H. & Cunha, B.A. (2001). Infections associated with steroid use. Infectious Disease Clinics of North America 15, 423-432.
2. Sia, I.G. & Paya, C.V. (1998). Infectious complications following renal transplantation. The Surgical Clinics of North America 78, 95-112. (Pubitemid 28117516)
3. Sleijffers, A., Garssen, J. & van Loveren, H. (2003). Ultraviolet radiation, resistance to infectious diseases, and vaccination responses. Methods 28, 111-121.
4. Vial, T. & Descotes, J. (2003). Immunosuppressive drugs and cancer. Toxicology 185, 229-240.
5. Demoly, P. & Bousquet, J. (2001). Epidemiology of drug allergy. Current Opinions in Allergy & Clinical Immunology 1, 305-310.
6. Miossec, P. (2001). Cytokine-induced autoimmune disorders. Drug Safety 17, 93-104.
7. Bini, E.J. & Weinshel, E.H. (1999). Severe exacerbation of asthma: a new side effect of interferon-alpha in patients with asthma and chronic hepatitis C. Mayo Clinic Proceedings 74, 367-370.
8. Gerberick, G.F., Ryan, C.A., Dearman, R.J. & Kimber, I. (2007). Local lymph node assay (LLNA) for detection of sensitization capacity of chemicals. Methods 41, 54-60. (Pubitemid 44855638)
9. van den Berg, F.A., Baken, K.A., Vermeulen, J.P., Gremmer, E.R., van Steeg, H. & van Loveren, H. (2007). Use of the local lymph node assay in assessment of immune function. Toxicology 211, 107-114.
10. Weaver, J.L., Chapdelaine, J.M., Descotes, J., Germolec, D., Holsapple, M., House, R., Lebrec, H., Meade, J., Pieters, R., Hastings, K.L. & Dean, J.H. (2005). Evaluation of a lymph node proliferation assay for its ability to detect pharmaceuticals with potential to cause immune-mediated drug reactions. Journal of Immunotoxicology 2, 11-20. (Pubitemid 41702868)
11. House, R.V. (2000). An overview of in vitro/ex vivo assays for preclinical evaluation of immunomodulation. Human Experimental Toxicology 19, 246-250.
12. Gennari, A., Ban, M., Braun, A., Casati, S., Corsini, E., Dastych, J., Descotes, J., Hartung, T., HooghePeters, R., House, R., Pallardy, M., Pieters, R., Reid, L., Tryphonas, H., Tschirhart, E., Tuschl, H., Vandebriel, R. & Gribaldo, L. (2005). The use of in vitro systems for evaluating immunotoxicity. The report and recommendations of an ECVAM workshop. Journal of Immunotoxicology 2, 61-83. (Pubitemid 41702862)
13. Gerberick, G.F., Vassallo, J.D., Foertsch, L.M., Price, B.B., Chaney, J.G. & Lepoittevin, J.P. (2007). Quantification of chemical peptide reactivity for screening contact allergens: a classification tree model approach. Toxicological Sciences 97, 417-427.
14. Gerberick, G.F., Aleksic, M., Basketter, D.A., Casati, S., Karlberg, A.T., Kern, P., Kimber, I., Lepoittevin, J.P., Natsch, A., Ovigne, J.M., Rovida, C., Sakaguchi, H. & Schulz, T. (2008). Chemical reactivity measurement and the predicitve identification of skin sensitisers. The report and recommendations of ECVAM Workshop 64. ATLA 36, 215-242.
15. Barker, J.N., Mitra, R.S., Griffiths, C.E., Dixit, V.M. & Nickoloff, B.J. (1991). Keratinocytes as initiators of inflammation. Lancet 33, 211-214.
16. Katz, S.I., Tamaki, K. & Sachs, D.H. (1979). Epidermal Langerhans cells are derived from cells originating bone marrow. Nature, London 282, 324-326. (Pubitemid 10198536)
17. Grabbe, S., Steinert, M., Mahnke, K., Schwartz, A., Luger, T.A & Schwarz, T. (1996). Dissection of antigenic and irritative effects of epicutaneously applied haptens in mice. Evidence that not the antigenic component but non-specific proinflammatory effects of haptens determine the concentration-dependent elicitation of allergic contact dermatitis. Journal of Clinical Investigation 98, 1158-1164. (Pubitemid 26299929)
18. Enk, A.H. & Katz, S.I. (1992). Early molecular events in the induction phase of contact sensitivity. Proceedings of the National Academy of Sciences of the USA 89, 1398-1402.
19. Corsini, E., Primavera, A., Marinovich, M. & Galli, C.L. (1998). Selective induction of cell-associated interleukin-lalpha in murine keratinocytes by chemical allergens. Toxicology 129, 193-200. (Pubitemid 29023147)
20. van Och, F.M., van Loveren, H., van Wolfswinkel, J.C., Machielsen, A.J. & Vandebriel, R.J. (2005). Assessment of potency of allergenic activity of low molecular weight compounds based on IL-1alpha and IL-18 production by a murine and human keratinocyte cell line. Toxicology 210, 95-109.
21. Müller, G., Saloga, J., Germann, T., Bellinghausen, I., Mohamadzadeh, M., Knop, J. & Enk, A.H. (1994). Identification and induction of human keratinocyte-derived IL-12. Journal of Clinical Investigation 94, 1799-1805. (Pubitemid 24348215)
22. Corsini, E., Limiroli, E., Marinovich, M., Cohen, C., Roguet, R. & Galli, C.L. (1999). Selective induction of interleukin-12 by chemical allergens in reconstituted human epidermis. ATLA 27, 261-269. (Pubitemid 29196654)
23. Coutant, K.D., de Fraissinette, A.B., Cordier, A. & Ulrich, P. (1999). Modulation of the activity of human monocyte-derived dendritic cells by chemical haptens, a metal allergen, and a staphylococcal superantigen. Toxicological Sciences 52, 189-198. (Pubitemid 30017594)
24. Corsini, E., Mitjans, M., Galbiati, V., Lucchi, L., Galli, C.L. & Marinovich, M. (2009). Use of IL-18 production in a human keratinocyte cell line to discriminate contact sensitizers from irritants and low molecular weight respiratory allergens. Toxicology in Vitro 23, 789-796.
25. Aiba, S., Terunuma, A., Manome, H. & Tagami, H. (1997). Dendritic cells differently respond to haptens and irritants by their production of cytokines and expression of co-stimulatory molecules. European Journal of Immunology 27, 3031-3038. (Pubitemid 27478378)
26. Häcker, H., Mischak, H., Miethke, T., Liptay, S., Schmid, R., Sparwasser, T., Heeg, K., Lipford, G.B. & Wagner, H. (1998). CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation. EMBO Journal 17, 6230-6240. (Pubitemid 28497796)
27. Cella, M., Salio, M., Sakakibara, Y., Langen, H., Julkunen, I. & Lanzavecchia, A. (1999). Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. Journal of Experimental Medicine 189, 821-829. (Pubitemid 29189687)
28. Caux, C., Massacrier, C., Vanbervliet, B., Dubois, B., Van Kooten, C., Durand I. & Banchereau, J. (1994). Activation of human dendritic cells through CD40 cross-linking. Journal of Experimental Medicine 180, 1263-1272. (Pubitemid 24289600)
29. Caux, C., Dezutter-Dambuyant, C., Schmitt, D. & Banchereau, J. (1992). GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature, London 360, 258-261.
30. Degwert, J.S., Hoppe, U. & Kligman, L.H. (1997). In vitro model for contact sensitization: I. Stimulatory capacities of human blood-derived dendritic cells and their phenotypical alterations in the presence of contact sensitizers. Toxicology in Vitro 11, 613-618.
31. Rougier, N., Redziniak, G., Mougin, D., Schmitt, D. & Vincent, C. (2000). In vitro evaluation of the sensitization potential of weak contact allergens using Langerhans-like dendritic cells and autologous T cells. Toxicology 145, 73-82.
32. 2 and SDS. Toxicology in Vitro 15, 319-325. (Pubitemid 32889651)
33. Weigt, H., Muhlradt, P.F., Larbig, M., Krug, N. & Braun, A. (2004). The toll-like receptor-2/6 agonist macrophage-activating lipopeptide-2 cooperates with IFN-gamma to reverse the Th2 skew in an in vitro allergy model. Journal of Immunology 172, 6080-6086. (Pubitemid 38621210)
34. Aiba, S., Manome, H., Yoshino, Y. & Tagami, H. (2000). In vitro treatment of human transforming growth factor-beta1-treated monocyte-derived dendritic cells with haptens can induce the phenotypic and functional changes similar to epidermal Langerhans cells in the initiation phase of allergic contact sensitivity reaction. Immunology 101, 68-75.
35. Tuschl, H., Kovac, R. & Weber, E. (2000). The expression of surface markers on dendritic cells as indicators for the sensitizing potential of chemicals. Toxicology in Vitro 14, 541-549. (Pubitemid 30734286)
36. Arrighi, J.F., Rebsamen, M., Rousset, F., Kindler, V. & Hauser, C. (2001). A critical role for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide, TNF-alpha, and contact sensitizers. Journal of Immunology 166, 3837-3845. (Pubitemid 32224909)
37. 2 and 2,4-dinitrochlorobenzene. Journal of Investigative Dermatology 120, 390-399. (Pubitemid 36298424)
38. Casati, S., Aeby, P., Basketter, D.A., Cavani, A., Gennari, A., Gerberick, G.F., Griem, P., Hartung, T., Kimber, I., Lepoittevin, J-P., Meade, B.J., Pallardy, M., Rougier, N., Rousset, F., Rubinstenn, G., Sallusto, F., Verheyen, G.R. & Zuang, V. (2005). Dendritic cells as a tool for the predictive identification of skin sensitisation hazard. ATLA 33, 47-62. (Pubitemid 40476882)
39. dos Santos, G.G., Reinders, J., Ouwehand, K., Rustemeyer, T., Scheper, R.J. & Gibbs, S. (2009). Progress on the development of human in vitro dendritic cell based assays for assessment of the sensitizing potential of a compound. Toxicology & Applied Pharmacology 236, 372-382.
40. Ashikaga, T., Hoya, M., Itagaki, H., Katsumula, Y. & Aiba, S. (2002). Evaluation of CD86 expression and MHC class II molecule internalization in THP-1 human monocytic cells as predictive endpoints for contact sensitizers. Toxicology in Vitro 16, 711-716. (Pubitemid 35356278)
41. Yoshida, Y., Skaguchi, H., Ito, Y., Okuda, M. & Suzuki, H. (2003). Evaluation of chemicals using expression of co-stimulatory molecules, CD54 and CD86, on the naïve THP-1 cell line. Toxicology in Vitro 17, 221-228.
42. Mitjans, M., Viviani, B., Lucchi, L., Galli, C.L., Marinovich, M. & Corsini, E. (2008). Role of p38 MAPK in the selective release of IL-8 induced by chemical allergen in naïve THP-1 cells. Toxicology in Vitro 22, 386-395. (Pubitemid 351163546)
43. Wohlsen, A., Martin, C., Vollmer, E., Branscheid, D., Magnussen, H., Becker, W.M., Lepp, U. & Uhlig, S. (2003). The early allergic response in small airways of human precision-cut lung slices. European Respiratory Journal 21, 1024-1032. (Pubitemid 36675621)
44. Henjakovic, M., Martin, C., Hoymann, H.G., Sewald, K., Ressmeyer, A.R., Dassow, C., Pohlmann, G., Krug, N., Uhlig, S. & Braun, A. (2008). Ex vivo lung function measurements in precision-cut lung slices (PCLS) from chemical allergen-sensitized mice represent a suitable alternative to in vivo studies. Toxicological Sciences 106, 444-453.
45. Pessina, A., Albella, B., Bueren, J., Brantom, P., Casati, S., Gribaldo, L., Croera, C., Gagliardi, G., Foti, P., Parchment, R., Parent-Massin, D., Sibiril, Y. & Van Den Heuvel, R. (2001). Prevalidation of a model for predicting acute neutropenia by colony forming unit granulocyte/macrophage (CFU-GM) assay. Toxicology in Vitro 15, 729-740. (Pubitemid 33043962)
46. Mishell, R.I. & Dutton, R.W. (1967). Immunization of dissociated spleen cell cultures from normal mice. Journal of Experimental Medicine 126, 423-442.
47. Fauci, A.S. & Pratt, K.R. (1976). Activation of human B lymphocytes. I. Direct plaque-forming cell assay for the measurement of polyclonal activation and antigenic stimulation of human B lymphocytes. Journal of Experimental Medicine 144, 674-684.
48. Lebrec, H., Roger, R., Blot, C., Burleson, G.R., Bohuon, C. & Pallardy, M. (1995). Immunotoxicological investigation using pharmaceutical drugs. In vitro evaluation of immune effects using rodent or human immune cells. Toxicology 96, 147-156.
49. Condevaux, F., Guichard, J., Forichon, A., Aujoulat, M. & Descotes, J. (2001). Compared effects of morphine and nickel chloride on NK cell activity in vitro in rats and monkeys. Journal of Applied Toxicology 21, 431-434.
50. Flavell, R.A., Dong, C. & Davis, R.J. (2002). Signaling and cell death in lymphocytes. Inflammation Research 51, 80-82. (Pubitemid 34183630)
51. + T-lymphocytes: new partners in TCR/CD28 signal integration. Molecular Immunology 38, 1087-1099.
52. House, R.V. (2001). Cytokine measurement techniques for assessing hypersensitivity. Toxicology 158, 51-58.
53. Carfi, M., Gennari, A., Malerba, I., Corsini, E., Pallardy, M., Pieters, R., van Loveren, H., Vohr, H.W., Hartung, T. & Gribaldo, L. (2007). In vitro tests to evaluate immunotoxicity: a preliminary study. Toxicology 229, 11-22.
54. Thurm, C.W. & Halsey, J.F. (2005). Measurement of cytokine production using whole blood. Current Protocols in Immunology Chapter 7: Unit 7.18B.
55. Langezaal, I., Coecke, S. & Hartung, T. (2001). Whole blood cytokine response as a measure of immunotoxicity. Toxicology in Vitro 15, 313-318. (Pubitemid 32889650)
56. Hermann, C., von Aulock, S., Graf, K. & Hartung, T. (2003). A model of human whole blood lymphokine release for in vitro and ex vivo use. Journal of Immunological Methods 275, 69-79. (Pubitemid 36351543)
57. Langezaal, I., Hoffmann, S., Hartung, T. & Coecke, S. (2002). Evaluation and prevalidation of an immunotoxicity test based on human whole-blood cytokine release. ATLA 30, 581-595. (Pubitemid 36168750)
58. Maino, V.C. & Picker, L.J. (1998). Identification of functional subsets by flow cytometry: intracellular detection of cytokine expression. Cytometry 34, 207-215. (Pubitemid 28507017)
59. Chamberlain, P. (2008). Presenting an immunogenicity risk assessment to regulatory agencies. In Immunogenicity of Biopharmaceuticals (ed. M. van de Weert & E. Horn Moller), pp. 239-258. New York, NY, USA: AAPS Press, Springer.
60. Roggen, E. (2008). Models for prediction of immunogenicity. In Immunogenicity of Biopharmaceuticals (ed. M. van de Weert & E. Horn Møller), pp. 75-95. New York, NY, USA: AAPS Press, Springer.
61. Gorbachev, A.V. & Fairchild, R.L. (2001). Induction and regulation of T-cell priming for contact hypersensitivity. Critical Reviews in Immunology 21, 451-472.
62. Grabbe, S. & Schwarz, T. (1996). Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity. American Journal of Contact Dermatitis 7, 238-246. (Pubitemid 26414482)
63. Langenkamp, A., Casorati, G., Garavaglia, C., Dellabona, P., Lanzavecchia, A. & Sallusto, F. (2002). T cell priming by dendritic cells: thresholds for proliferation, differentiation and death and intraclonal functional diversification. European Journal of Immunology 32, 2046-2054.
64. Rustemeyer, T., De Ligter, S., Von Blomberg, B.M., Frosch, P.J. & Scheper, R.J. (1999). Human T lymphocyte priming in vitro by haptenated autologous dendritic cells. Clinical & Experimental Immunology 117, 209-216. (Pubitemid 29343589)
65. Dai, R. & Streilein, J.W. (1998). Naïve, hapten-specific human T lymphocytes are primed in vitro with derivatized blood mononuclear cells. Journal of Investigative Dermatology 110, 29-33. (Pubitemid 28086059)
66. Byers, A.M., Tapia, T.M., Sassano, E.R. & Wittman, V. (2009). In vitro antibody response to tetanus in the MIMIC system is a representative measure of vaccine immunogenicity. Biologicals 37, 148-151.
67. Howes, D., Guy, R., Hadgraft, J., Heylings, J., Hoeck, U., Kemper, F., Maibach, H., Marty, J-P., Merk, H., Parra, J., Rekkas, D., Rondelli, I., Schaefer, H., Täuber, U. & Verbiese, N. (1996). Methods for assessing percutaneous absorption. The report and recommendations of ECVAM Workshop 13. ATLA 24, 81-106.
68. Basketter, D.A., Pease, C., Kasting, G., Kimber, I., Casati, S., Cronin, M., Diembeck, W., Gerberick, F., Hadgraft, J., Hartung, T., Marty, J-P., Nikolaidis, E., Patlewicz, G., Roberts, D., Roggen, E., Rovida, C. & van de Sandt, J. (2007). Skin sensitisation and epidermal disposition: the relevance of epidermal disposition for sensitisation hazard identification and risk assessment. The report and recommendations of ECVAM Workshop 59. ATLA 35, 137-154.
69. Netzeva, T.I., Worth, A.P., Aldenberg, T., Benigni, R., Cronin, M.T.D., Gramatica, P., Jaworska, J.S., Kahn, S., Klopman, G., Marchant, C.A., Myatt, G., Nikolova-Jeliazkova, N., Patlewicz, G.Y., Perkins, R., Roberts, D.W., Schultz, T.W., Stanton, D.T., van de Sandt, J.J.M., Tong, W., Veith, G. & Yang, C. (2005). Current status of methods for defining the applicability domain of (quantitative) structure - activity relationships. The report and recommendations of ECVAM Workshop 52. ATLA 33, 155-173.
70. Patlewicz, G., Aptula, A.O., Uriarte, E., Roberts, D.W., Kern, P.S., Gerberick, G.F., Kimber, I., Dearman, R.J., Ryan, C.A. & Basketter, D.A. (2007). An evaluation of selected global (Q)SARs/expert systems for the prediction of skin sensitisation potential. SAR & QSAR in Environmental Research 18, 515-541. (Pubitemid 47182746)
71. Van de Sandt, J.J., Roguet, R., Cohen, C., Esdaille, D., Ponec, M., Corsini, E., Barker, C., Fusenig, N., Liebsch, M., Benford, D., de Brugerolle de Fraissinette, A. & Fartasch, M. (1999). The use of human keratinocytes and human skin models for predicting skin irritation. The report and recommendations of ECVAM Workshop 38. ATLA 27, 723-743.